Basislinie- vurderinger, inklusive TWSTRS og VAS smerteevaluering, evalueret af patienten og investigatoren, blev gentaget 4, 8 og 12 uger efter behandlingen.
Baseline assessments, including TWSTRS and VAS pain evaluation by patient and investigator, were repeated at 4, 8 and 12 weeks after treatment.